Two-Stage Experimental Design for Dose-Response Modeling in Toxicology Studies.

The efficient design of experiments (i.e., selection of experimental doses and allocation of animals) is important to establishing dose-response relationships in toxicology studies. The proposed procedure for design of experiments is distinct from those in the literature because it is able to adequately accommodate the special features of the dose-response data, which include non-normality, variance heterogeneity, possibly nonlinearity of the dose-response curve, and data scarcity. The design procedure is built in a sequential two-stage paradigm that allows for a learning process. In the first stage, preliminary experiments are performed to gain information regarding the underlying dose-response curve and variance structure. In the second stage, the prior information obtained from the previous stage is utilized to guide the second-stage experiments. An optimization algorithm is developed to search for the design of experiments that will lead to dose-response models of the highest quality. To evaluate model quality (or uncertainty), which is the basis of design optimization, a bootstrapping method is employed; unlike standard statistical methods, bootstrapping is not subject to restrictive assumptions such as normality or large sample sizes. The design procedure in this paper will help to reduce the experimental cost/time in toxicology studies and alleviate the sustainability concerns regarding the tremendous new materials and chemicals.

[1]  R J Kavlock,et al.  A simulation study of the influence of study design on the estimation of benchmark doses for developmental toxicity. , 1995, Risk analysis : an official publication of the Society for Risk Analysis.

[2]  Anthony C. Davison,et al.  Bootstrap Methods and Their Application , 1998 .

[3]  Nianqiang Wu,et al.  Detection of mercury(II) by quantum dot/DNA/gold nanoparticle ensemble based nanosensor via nanometal surface energy transfer. , 2011, Analytical chemistry.

[4]  W. J. Langford Statistical Methods , 1959, Nature.

[5]  Feng Yang,et al.  Differential mouse pulmonary dose and time course responses to titanium dioxide nanospheres and nanobelts. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  Frank Bretz,et al.  Dose Finding – A Challenge in Statistics , 2008, Biometrical journal. Biometrische Zeitschrift.

[7]  Weng Kee Wong,et al.  A unified approach to the construction of minimax designs , 1992 .

[8]  Ayyakkannu Manivannan,et al.  Reduced graphene oxide/titanium dioxide composites for supercapacitor electrodes: shape and coupling effects , 2012 .

[9]  Nianqiang Wu,et al.  Porous CuO–ZnO nanocomposite for sensing electrode of high-temperature CO solid-state electrochemical sensor , 2005 .

[10]  D. Wiens Minimax Robust Designs and Weights for Approximately Specified Regression Models With Heteroscedastic Errors , 1998 .

[11]  Anthony C. Atkinson,et al.  D-Optimum Designs for Heteroscedastic Linear Models , 1995 .

[12]  Wout Slob,et al.  Dose-response modeling of continuous endpoints. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  Holger Dette,et al.  Bayesian D-optimal designs on a fixed number of design points for heteroscedastic polynomial models , 1998 .

[14]  W. Slob,et al.  Mathematical modelling and quantitative methods. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[15]  Nianqiang Wu,et al.  Impedance-metric Pt/YSZ/Au–Ga2O3 sensor for CO detection at high temperature , 2005 .

[16]  Nianqiang Wu,et al.  Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. , 2010, Toxicology.

[17]  B. Turnbull,et al.  Group Sequential Methods with Applications to Clinical Trials , 1999 .

[18]  K M Higgins,et al.  The effect of serial dilution error on calibration inference in immunoassay. , 1998, Biometrics.

[19]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[20]  P. Laycock,et al.  Optimum Experimental Designs , 1995 .

[21]  Kristi Kuljus,et al.  Comparing experimental designs for benchmark dose calculations for continuous endpoints. , 2006, Risk analysis : an official publication of the Society for Risk Analysis.

[22]  Holger Dette,et al.  Optimal Designs for Dose-Finding Studies , 2008 .

[23]  Anthony C. Atkinson,et al.  Optimum Experimental Designs , 1992 .

[24]  W. Wong G-optimal designs for multi-factor experiments with heteroscedastic errors , 1994 .

[25]  M Davidian,et al.  Some general estimation methods for nonlinear mixed-effects models. , 1993, Journal of biopharmaceutical statistics.

[26]  Weng Kee Wong,et al.  An algorithmic construction of optimal minimax designs for heteroscedastic linear models , 2000 .

[27]  W. J. Studden,et al.  Compromise designs in heteroscedastic linear models , 1992 .

[28]  Peter Goos,et al.  Efficient Bayesian designs under heteroscedasticity , 2002 .

[29]  Ayyakkannu Manivannan,et al.  Highly conductive electrospun carbon nanofiber/MnO2 coaxial nano-cables for high energy and power density supercapacitors , 2012 .

[30]  Holger Dette,et al.  Optimal designs for dose-finding experiments in toxicity studies , 2009, 0902.1426.

[31]  Daniel Krewski,et al.  Optimal Designs for Estimating the Effective Dose in Developmental Toxicity Experiments , 2002, Risk analysis : an official publication of the Society for Risk Analysis.

[32]  J. Tukey,et al.  Variations of Box Plots , 1978 .

[33]  Marie Davidian,et al.  Nonlinear Models for Repeated Measurement Data , 1995 .

[34]  Marie Davidian,et al.  Bootstrap-Adjusted Calibration Confidence Intervals for Immunoassay , 1997 .

[35]  G Dunn,et al.  'Optimal' designs for drug, neurotransmitter and hormone receptor assays. , 1988, Statistics in medicine.

[36]  Salomon Sand,et al.  Dose-response modeling and benchmark calculations from spontaneous behavior data on mice neonatally exposed to 2,2',4,4',5-pentabromodiphenyl ether. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  Robert Tibshirani,et al.  An Introduction to the Bootstrap , 1994 .

[38]  N. Wu,et al.  Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity , 2009, Particle and Fibre Toxicology.

[39]  W. J. Studden,et al.  Optimal designs with respect to Elfving's partial minimax criterion in polynomial regression , 1994 .

[40]  D. Ruppert,et al.  Transformation and Weighting in Regression , 1988 .

[41]  A. Gelman,et al.  Bayesian Analysis of Serial Dilution Assays , 2004, Biometrics.

[42]  Averill M. Law,et al.  Simulation Modeling and Analysis , 1982 .

[43]  B. Turnbull,et al.  Group Sequential Methods , 1999 .

[44]  Nianqiang Wu,et al.  Detection of adenosine triphosphate with an aptamer biosensor based on surface-enhanced Raman scattering. , 2012, Analytical chemistry.

[45]  Salomon Sand,et al.  The Benchmark Dose Method—Review of Available Models, and Recommendations for Application in Health Risk Assessment , 2003, Critical reviews in toxicology.

[46]  Andrej Pázman,et al.  Nonlinear Regression , 2019, Handbook of Regression Analysis With Applications in R.

[47]  Nianqiang Wu,et al.  In situ construction of a titanate–silver nanoparticle–titanate sandwich nanostructure on a metallic titanium surface for bacteriostatic and biocompatible implants , 2012 .